Lung adenocarcinoma stage IA usually requires genetic testing.
Lung adenocarcinoma stage IA refers to adenocarcinoma, relatively early lung cancer. Lung adenocarcinoma stage IA requires genetic testing, which can prepare for follow-up treatment. Early stage lung adenocarcinoma may also have the risk of recurrence and metastasis. Taking biopsy and doing genetic test earlier can prepare for the treatment of recurrence and metastasis, because some lung cancer patients are difficult to take biopsy and do genetic test after recurrence and metastasis.
Stage IA lung adenocarcinoma is defined as a tumor with maximum diameter less than or equal to 3cm, surrounded by lung tissue and visceral pleura, with invasion of lobar bronchus but not main bronchus by bronchoscopy, and without lymph node and distant metastasis. Adenocarcinoma is non-small cell lung cancer, which can be treated by radical surgery, chemotherapy and radiotherapy according to the actual situation.
Patients with stage IA lung adenocarcinoma should keep a positive mindset, cooperate with doctor’s treatment, and undergo regular review to improve the quality of life.